Intercept shares quadruple on surprise liver drug data

(Reuters) – Intercept Pharmaceuticals Inc’s drug to treat liver disease caused by fat buildup was found effective in a trial, paving the way for it to become the first approved treatment for the…

    

Leave a Reply

Your email address will not be published.